Patents Assigned to Bioventure Investments, kft
  • Chimeric antibody with specificity to human B cell surface antigen
    Patent number: 6120767
    Abstract: A chimeric antibody with human constant region and murine variable region, having specificity to a 35 kDA polypeptide (Bp35(CD20)) expressed on the surface of human B cells, methods of production, and uses.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: September 19, 2000
    Assignees: Pharmaceutical Royalties, L.L.C., Bioventure Investments, kft
    Inventors: Randy R. Robinson, Alvin Y. Liu, Jeffrey A. Ledbetter